Fortress Biotech
FBIO
#10157
Rank
NZ$0.11 B
Marketcap
NZ$3.45
Share price
0.52%
Change (1 day)
-19.02%
Change (1 year)

Earnings for Fortress Biotech (FBIO)

Earnings in 2026 (TTM): NZ$0.25 Billion

According to Fortress Biotech 's latest financial reports the company's current earnings are NZ$68.46 Million. In 2025 the company made an earning of -NZ$59.99 Million, an increase over its 2024 earnings that were of -NZ$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fortress Biotech from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.25 B-522.4%
2025 -NZ$59.99 Million-72.02%
2024 -NZ$0.22 Billion-21.6%
2023 -NZ$0.28 Billion-28.03%
2022 -NZ$0.38 Billion29.88%
2021 -NZ$0.3 Billion59.8%
2020 -NZ$0.19 Billion1.17%
2019 -NZ$0.19 Billion-19.84%
2018 -NZ$0.23 Billion28.99%
2017 -NZ$0.18 Billion37.92%
2016 -NZ$0.13 Billion32.31%
2015 -NZ$95.9 Million164.31%
2014 -NZ$36.29 Million-45.14%
2013 -NZ$66.14 Million37.55%
2012 -NZ$48.08 Million-22.91%
2011 -NZ$62.37 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Veracyte
VCYT
NZ$0.20 B-20.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion-180.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
-NZ$60.56 Million-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
-NZ$60.32 Million-123.23%๐Ÿ‡บ๐Ÿ‡ธ USA